The estimated Net Worth of James Edeerfield Management... is at least $13.7 millió dollars as of 25 June 2018. James Management owns over 114,034 units of Avadel Pharmaceuticals plc stock worth over $12,998,417 and over the last 6 years James sold AVDL stock worth over $683,064.
James has made over 1 trades of the Avadel Pharmaceuticals plc stock since 2018, according to the Form 4 filled with the SEC. Most recently James sold 114,034 units of AVDL stock worth $683,064 on 25 June 2018.
The largest trade James's ever made was selling 114,034 units of Avadel Pharmaceuticals plc stock on 25 June 2018 worth over $683,064. On average, James trades about 114,034 units every 0 days since 2018. As of 25 June 2018 James still owns at least 952,265 units of Avadel Pharmaceuticals plc stock.
You can see the complete history of James Management stock trades at the bottom of the page.
James's mailing address filed with the SEC is 780 3rd Ave, New York, NY 10017, USA.
Over the last 8 years, insiders at Avadel Pharmaceuticals plc have traded over $7,791,038 worth of Avadel Pharmaceuticals plc stock and bought 775,568 units worth $4,366,224 . The most active insiders traders include Healthcare Master Fund Ltd ..., Kevin Broadfin Capital, Llc... és Naseem Amin. On average, Avadel Pharmaceuticals plc executives and independent directors trade stock every 43 days with the average trade being worth of $381,436. The most recent stock trade was executed by Thomas S Mchugh on 16 January 2024, trading 2,000 units of AVDL stock currently worth $29,000.
avadel pharmaceuticals plc (nasdaq: avdl) is a specialty pharmaceutical company that seeks to develop differentiated pharmaceutical products that are safe, effective and easy to take, helping patients adhere to their prescribed medical treatment and see better results. avadel’s current portfolio of products and product candidates focuses on the urology, central nervous system (cns) / sleep, and hospital markets. the company is headquartered in dublin, ireland with operations in st. louis, missouri and lyon, france.
Avadel Pharmaceuticals plc executives and other stock owners filed with the SEC include: